The impact of the Oncotype DX recurrence score pathology-clinical (RSPC) on the predicted recurrence risk for node negative breast cancer patients: A cancer center experience.
Barbara A. Wexelman
No relevant relationships to disclose
Alexander Gallagher
No relevant relationships to disclose
Barbara L. Smith
No relevant relationships to disclose
Steven J. Isakoff
No relevant relationships to disclose